APA (7th ed.) Citation

Kampa-Schittenhelm, K. M., Salitzky, O., Akmut, F., Illing, B., Kanz, L., Salih, H. R., & Schittenhelm, M. M. (2016). Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns. BMC Cancer, 16, 1. https://doi.org/10.1186/s12885-015-2029-8

Chicago Style (17th ed.) Citation

Kampa-Schittenhelm, Kerstin Maria, Olaf Salitzky, Figen Akmut, Barbara Illing, Lothar Kanz, Helmut Rainer Salih, and Marcus Matthias Schittenhelm. "Dronabinol Has Preferential Antileukemic Activity in Acute Lymphoblastic and Myeloid Leukemia with Lymphoid Differentiation Patterns." BMC Cancer 16 (2016): 1. https://doi.org/10.1186/s12885-015-2029-8.

MLA (9th ed.) Citation

Kampa-Schittenhelm, Kerstin Maria, et al. "Dronabinol Has Preferential Antileukemic Activity in Acute Lymphoblastic and Myeloid Leukemia with Lymphoid Differentiation Patterns." BMC Cancer, vol. 16, 2016, p. 1, https://doi.org/10.1186/s12885-015-2029-8.